Drugs / MEOPA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02198378 | Nov 2014 → Jan 2017 | acute coronary syndrome | University Hospital, Toulouse | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MEOPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02198378 ↗ |
| Modality | Other / unclassified | “The equimolar oxygen/nitrous oxide mixture (MEOPA) is widely used in emergency medicine” NCT02198378 ↗ |
| Route | Inhaled | “The patient breathes normally in the mask which is held in place by a member of the SMUR team who has received previous training in use of MEOPA.” NCT02198378 ↗ |